Endocrinology, Metabolism & Liver session-7: From Bench to Breakthroughs: Future Therapeutic Frontiers in Metabolic Disorders
Tracks
Track 3
| Friday, June 5, 2026 |
| 11:00 AM - 12:30 PM |
Speaker
Gema Frühbeck
Clínica Universidad De Navarra
From the ABCD of obesity to a new framework for the diagnosis and management of obesity in adults
11:00 AM - 11:20 AMBiography
Prof. Gema Frühbeck (RNutr, MD, PhD) combines everyday work in the clinical setting as Co-Director of the Obesity Area of the Clínica Universidad de Navarra (Pamplona, Spain), with basic research as Head of the Metabolic Research Laboratory of the University of Navarra and Project Leader of the CIBEROBN (Centre of Excellence Network in Obesity and Nutrition of the Spanish Institute of Health). The efforts of her group are focused on studying the impact of adiposity on the development of comorbidities. Frühbeck’s group has taken the step forward of using body composition measurements routinely in the clinical assessment of patients in order to analyse the relevance of body fat -beyond BMI- in comorbidity development.
Cyrielle Caussy
Hospices Civils De Lyon
Anti-obesity therapies and effect on MASH, only a matter of weight loss?
11:20 AM - 11:40 AMBiography
Silvio Buscemi
University of Palermo
Pleiotropic effects of incretin-based therapies: from organ-specific mechanisms to a systemic cardio–hepato–metabolic–renal paradigm
11:40 AM - 12:00 PMBiography
Silvio Buscemi, MD, PhD, is Full Professor with extensive clinical and academic expertise in obesity and diabetes. He is based at the University of Palermo (Italy), where he is actively engaged in clinical practice, research, and teaching at the University Hospital Policlinico “P. Giaccone”. He directs the Unit of Clinical Nutrition, Obesity and Metabolic Diseases and serves as Director of the Residency Program in Human Nutrition.
His research focuses on the pathophysiology of metabolic diseases, as well as the prevention and management of obesity and diabetes, with particular emphasis on innovative therapeutic strategies. He has authored numerous peer-reviewed publications in international journals and is actively involved in multicenter clinical studies and research projects. He is a frequent speaker at national and international conferences and is committed to the training of medical students and residents.
He currently serves as President of the Italian Society of Obesity (SIO).
Amar Van Laar
Postdoctoral Scientist
Ku Leuven
Optimization and expansion of the Edmonton Obesity Staging System framework
12:00 PM - 12:15 PMBiography
Candela Diaz Canestro
Group Leader
University Of Zurich
Multi-Omics Signatures of Circulating Exerkines Predict Cardiorespiratory Fitness Adaptations in Individuals With Prediabetes
12:15 PM - 12:30 PMBiography
Alessandra Pistillo
Fondazione Policlinico Universitario “A. Gemelli” IRCCS, Rome, Italy.
Integrated phenotyping of the gut-platelet-liver axis in the progression of MASLD-related chronic liver disease
12:15 PM - 12:30 PMBiography
Chair
Rita Machado de Oliveira
Nova Medical School, Lisbon, Portugal
